Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia

Leonardo Mirandola, Maurizio Chiriva-Internati, Daniela Montagna, Franco Locatelli, Marco Zecca, Marco Ranzani, Andrea Basile, Massimo Locati, Everardo Cobos, W. Martin Kast, Rosanna Asselta, Elvezia Maria Paraboschi, Paola Comi, Raffaella Chiaramonte

Research output: Contribution to journalArticle

Abstract

Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation. Notch1 pathway activation is seen in T cell acute lymphoblastic leukaemia (T-ALL) due to the high frequency of Notch1 mutations affecting approximately 60% of patients, causing ligand-independent signalling and/or prolonging Notch1 half-life. We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia. We inhibited the pathway through γ-Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors. Our results indicate that γ-Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered. The Notch pathway also controls CCR5- and CCR9-mediated biological effects, ie chemotaxis and proliferation. Furthermore, engaging CCR9 through CCL25 administration rescues proliferation inhibition associated with abrogation of Notch activity. Finally, through RNA interference we demonstrated that the oncogenic isoform in T-ALL, Notch1, plays a role in controlling CCR5 and CCR9 expression and functions. These findings suggest that Notch1, acting in concert with chemokine receptors pathways, may provide leukaemia cells with proliferative advantage and specific chemotactic abilities, therefore influencing tumour cell progression and localization.

Original languageEnglish
Pages (from-to)713-722
Number of pages10
JournalJournal of Pathology
Volume226
Issue number5
DOIs
Publication statusPublished - Apr 2012

Fingerprint

CCR5 Receptors
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Chemokine Receptors
Chemotaxis
Amyloid Precursor Protein Secretases
Leukemia
RNA Interference
Neoplasms
Aptitude
Mutation Rate
Cell Movement
Half-Life
Protein Isoforms
Cell Proliferation
Ligands
Cell Line
CC chemokine receptor 9

Keywords

  • CCL25
  • CCR5
  • CCR7
  • CCR9
  • Chemokine receptor
  • Chemotaxis
  • CXCR4
  • Notch
  • Proliferation
  • T cell acute lymphoblastic leukaemia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia. / Mirandola, Leonardo; Chiriva-Internati, Maurizio; Montagna, Daniela; Locatelli, Franco; Zecca, Marco; Ranzani, Marco; Basile, Andrea; Locati, Massimo; Cobos, Everardo; Kast, W. Martin; Asselta, Rosanna; Paraboschi, Elvezia Maria; Comi, Paola; Chiaramonte, Raffaella.

In: Journal of Pathology, Vol. 226, No. 5, 04.2012, p. 713-722.

Research output: Contribution to journalArticle

Mirandola, Leonardo ; Chiriva-Internati, Maurizio ; Montagna, Daniela ; Locatelli, Franco ; Zecca, Marco ; Ranzani, Marco ; Basile, Andrea ; Locati, Massimo ; Cobos, Everardo ; Kast, W. Martin ; Asselta, Rosanna ; Paraboschi, Elvezia Maria ; Comi, Paola ; Chiaramonte, Raffaella. / Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia. In: Journal of Pathology. 2012 ; Vol. 226, No. 5. pp. 713-722.
@article{61aa7a8697e24b5ab6e988c40a84ea1d,
title = "Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia",
abstract = "Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation. Notch1 pathway activation is seen in T cell acute lymphoblastic leukaemia (T-ALL) due to the high frequency of Notch1 mutations affecting approximately 60{\%} of patients, causing ligand-independent signalling and/or prolonging Notch1 half-life. We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia. We inhibited the pathway through γ-Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors. Our results indicate that γ-Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered. The Notch pathway also controls CCR5- and CCR9-mediated biological effects, ie chemotaxis and proliferation. Furthermore, engaging CCR9 through CCL25 administration rescues proliferation inhibition associated with abrogation of Notch activity. Finally, through RNA interference we demonstrated that the oncogenic isoform in T-ALL, Notch1, plays a role in controlling CCR5 and CCR9 expression and functions. These findings suggest that Notch1, acting in concert with chemokine receptors pathways, may provide leukaemia cells with proliferative advantage and specific chemotactic abilities, therefore influencing tumour cell progression and localization.",
keywords = "CCL25, CCR5, CCR7, CCR9, Chemokine receptor, Chemotaxis, CXCR4, Notch, Proliferation, T cell acute lymphoblastic leukaemia",
author = "Leonardo Mirandola and Maurizio Chiriva-Internati and Daniela Montagna and Franco Locatelli and Marco Zecca and Marco Ranzani and Andrea Basile and Massimo Locati and Everardo Cobos and Kast, {W. Martin} and Rosanna Asselta and Paraboschi, {Elvezia Maria} and Paola Comi and Raffaella Chiaramonte",
year = "2012",
month = "4",
doi = "10.1002/path.3015",
language = "English",
volume = "226",
pages = "713--722",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia

AU - Mirandola, Leonardo

AU - Chiriva-Internati, Maurizio

AU - Montagna, Daniela

AU - Locatelli, Franco

AU - Zecca, Marco

AU - Ranzani, Marco

AU - Basile, Andrea

AU - Locati, Massimo

AU - Cobos, Everardo

AU - Kast, W. Martin

AU - Asselta, Rosanna

AU - Paraboschi, Elvezia Maria

AU - Comi, Paola

AU - Chiaramonte, Raffaella

PY - 2012/4

Y1 - 2012/4

N2 - Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation. Notch1 pathway activation is seen in T cell acute lymphoblastic leukaemia (T-ALL) due to the high frequency of Notch1 mutations affecting approximately 60% of patients, causing ligand-independent signalling and/or prolonging Notch1 half-life. We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia. We inhibited the pathway through γ-Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors. Our results indicate that γ-Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered. The Notch pathway also controls CCR5- and CCR9-mediated biological effects, ie chemotaxis and proliferation. Furthermore, engaging CCR9 through CCL25 administration rescues proliferation inhibition associated with abrogation of Notch activity. Finally, through RNA interference we demonstrated that the oncogenic isoform in T-ALL, Notch1, plays a role in controlling CCR5 and CCR9 expression and functions. These findings suggest that Notch1, acting in concert with chemokine receptors pathways, may provide leukaemia cells with proliferative advantage and specific chemotactic abilities, therefore influencing tumour cell progression and localization.

AB - Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation. Notch1 pathway activation is seen in T cell acute lymphoblastic leukaemia (T-ALL) due to the high frequency of Notch1 mutations affecting approximately 60% of patients, causing ligand-independent signalling and/or prolonging Notch1 half-life. We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia. We inhibited the pathway through γ-Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors. Our results indicate that γ-Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered. The Notch pathway also controls CCR5- and CCR9-mediated biological effects, ie chemotaxis and proliferation. Furthermore, engaging CCR9 through CCL25 administration rescues proliferation inhibition associated with abrogation of Notch activity. Finally, through RNA interference we demonstrated that the oncogenic isoform in T-ALL, Notch1, plays a role in controlling CCR5 and CCR9 expression and functions. These findings suggest that Notch1, acting in concert with chemokine receptors pathways, may provide leukaemia cells with proliferative advantage and specific chemotactic abilities, therefore influencing tumour cell progression and localization.

KW - CCL25

KW - CCR5

KW - CCR7

KW - CCR9

KW - Chemokine receptor

KW - Chemotaxis

KW - CXCR4

KW - Notch

KW - Proliferation

KW - T cell acute lymphoblastic leukaemia

UR - http://www.scopus.com/inward/record.url?scp=84858000851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858000851&partnerID=8YFLogxK

U2 - 10.1002/path.3015

DO - 10.1002/path.3015

M3 - Article

C2 - 21984373

AN - SCOPUS:84858000851

VL - 226

SP - 713

EP - 722

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 5

ER -